Clinical Trial Update: Contrast Media Reduction and Removal in Patients With Chronic Kidney Disease (CKD) (PRESERV) [NA]

View source ↗

Summary

The PRESERV trial evaluating reduction and removal of contrast media in patients with chronic kidney disease was terminated; results were posted on 2016-12-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Contrast-induced Nephropathy

Snippet

Sponsor: Osprey Medical, Inc | Conditions: Radiographic Contrast Agent Nephropathy | NA | Status: TERMINATED | Results posted: 2016-12-12